Vivo Capital, LLC - SINOVAC BIOTECH LTD ownership

SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 29 filers reported holding SINOVAC BIOTECH LTD in Q2 2021. The put-call ratio across all filers is - and the average weighting 3.3%.

Quarter-by-quarter ownership
Vivo Capital, LLC ownership history of SINOVAC BIOTECH LTD
ValueSharesWeighting
Q3 2023$38,173,000
-93.8%
5,900,0000.0%4.18%
-90.2%
Q2 2023$615,369,4100.0%5,900,0000.0%42.48%
-0.5%
Q1 2023$615,369,410
+1611954.1%
5,900,0000.0%42.70%
+871.6%
Q4 2022$38,173
-99.9%
5,900,0000.0%4.40%
+4.3%
Q3 2022$38,173,0000.0%5,900,0000.0%4.21%
+9.9%
Q2 2022$38,173,0000.0%5,900,0000.0%3.83%
+45.8%
Q1 2022$38,173,0000.0%5,900,0000.0%2.63%
+14.2%
Q4 2021$38,173,0000.0%5,900,0000.0%2.30%
+34.3%
Q3 2021$38,173,0000.0%5,900,0000.0%1.71%
+3.8%
Q2 2021$38,173,0000.0%5,900,0000.0%1.65%
+23.1%
Q1 2021$38,173,0000.0%5,900,0000.0%1.34%
-21.2%
Q4 2020$38,173,0000.0%5,900,0000.0%1.70%
-22.8%
Q3 2020$38,173,0000.0%5,900,0000.0%2.21%
-19.4%
Q2 2020$38,173,0000.0%5,900,0000.0%2.74%
-20.9%
Q1 2020$38,173,0000.0%5,900,0000.0%3.46%
-3.3%
Q2 2019$38,173,0000.0%5,900,0000.0%3.58%
-6.0%
Q1 2019$38,173,000
-6.8%
5,900,0000.0%3.81%
-27.2%
Q4 2018$40,946,000
-8.9%
5,900,0000.0%5.23%
+15.4%
Q3 2018$44,958,0005,900,0004.53%
Other shareholders
SINOVAC BIOTECH LTD shareholders Q2 2021
NameSharesValueWeighting ↓
Orbimed Advisors 2,718,735$340,500,0006.32%
Vivo Capital, LLC 5,900,000$38,173,0004.21%
Neumann Advisory Hong Kong Ltd 315,586$2,0420.72%
Yorktown Management & Research Co Inc 74,893$485,0000.63%
Skandinaviska Enskilda Banken AB (publ) 40,000$259,0000.00%
Renaissance Technologies 2,375,841$1,537,0000.00%
WELLS FARGO & COMPANY/MN 1,687$11,0000.00%
NORTHERN TRUST CORP 13,787$55,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 412$27,0000.00%
View complete list of SINOVAC BIOTECH LTD shareholders